- EQS-PVR: MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-News: MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
- EQS-Adhoc: Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
- EQS-AFR: MorphoSys AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
- EQS-PVR: MorphoSys AG: Correction of a release from 18/04/2024 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-News: MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
- EQS-Adhoc: Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
- EQS-Adhoc: Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO
More ▼
Key statistics
As of last trade MorphoSys AG (MOR:NSQ) traded at 18.43, -5.49% below its 52-week high of 19.50, set on May 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.32 |
---|---|
High | 18.43 |
Low | 18.32 |
Bid | 18.37 |
Offer | 18.48 |
Previous close | 18.41 |
Average volume | 21.18k |
---|---|
Shares outstanding | 150.87m |
Free float | 126.33m |
P/E (TTM) | -- |
Market cap | 2.78bn USD |
EPS (TTM) | -3.40 USD |
Data delayed at least 15 minutes, as of Jul 29 2024 17:35 BST.
More ▼